Recent Finacing
Recent Raise
Thabor Therapeutics is a Paris-based biotech developing monoclonal antibody therapies targeting newly identified gut-secreted proteins that impair epithelial homeostasis to treat inflammatory bowel disease.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Thabor Therapeutics.
